BRPI0821553A2 - Usos de um peptídeo e de um sistema de dispensação para liberar um peptídeo, métodos para produzir uma composição cosmética e para triar peptídeos anti-dermatite seborréica, peptídeo, e, ácido nucleico - Google Patents

Usos de um peptídeo e de um sistema de dispensação para liberar um peptídeo, métodos para produzir uma composição cosmética e para triar peptídeos anti-dermatite seborréica, peptídeo, e, ácido nucleico

Info

Publication number
BRPI0821553A2
BRPI0821553A2 BRPI0821553-7A2A BRPI0821553A BRPI0821553A2 BR PI0821553 A2 BRPI0821553 A2 BR PI0821553A2 BR PI0821553 A BRPI0821553 A BR PI0821553A BR PI0821553 A2 BRPI0821553 A2 BR PI0821553A2
Authority
BR
Brazil
Prior art keywords
peptide
tribe
dermatitis
release
nucleic acid
Prior art date
Application number
BRPI0821553-7A2A
Other languages
English (en)
Inventor
Burghard Liebmann
Heike Brueser
Heiko Barg
Daniel Huemmerich
Hubertus Peter Bell
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of BRPI0821553A2 publication Critical patent/BRPI0821553A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0821553-7A2A 2007-12-21 2008-12-19 Usos de um peptídeo e de um sistema de dispensação para liberar um peptídeo, métodos para produzir uma composição cosmética e para triar peptídeos anti-dermatite seborréica, peptídeo, e, ácido nucleico BRPI0821553A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP07024988 2007-12-21
EP08159834 2008-07-07
US8070508P 2008-07-15 2008-07-15
PCT/EP2008/010912 WO2009080306A1 (en) 2007-12-21 2008-12-19 Anti-dandruff compositions containing peptides

Publications (1)

Publication Number Publication Date
BRPI0821553A2 true BRPI0821553A2 (pt) 2014-10-07

Family

ID=40419487

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821553-7A2A BRPI0821553A2 (pt) 2007-12-21 2008-12-19 Usos de um peptídeo e de um sistema de dispensação para liberar um peptídeo, métodos para produzir uma composição cosmética e para triar peptídeos anti-dermatite seborréica, peptídeo, e, ácido nucleico

Country Status (9)

Country Link
US (1) US8765688B2 (pt)
EP (1) EP2224901A1 (pt)
JP (1) JP5688293B2 (pt)
KR (2) KR101425331B1 (pt)
CN (1) CN101903011B (pt)
BR (1) BRPI0821553A2 (pt)
CA (1) CA2708554C (pt)
RU (1) RU2491052C2 (pt)
WO (1) WO2009080306A1 (pt)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008265231B2 (en) * 2007-06-20 2014-05-01 Basf Se Synthetic repetitive proteins, the production and use thereof
EP2224901A1 (en) * 2007-12-21 2010-09-08 Basf Se Anti-dandruff compositions containing peptides
JP2011530491A (ja) * 2008-08-08 2011-12-22 ビーエーエスエフ ソシエタス・ヨーロピア バイオポリマーに基づいた活性物質含有連続繊維層、その使用、およびその生産のための方法
JP2011530661A (ja) * 2008-08-08 2011-12-22 ビーエーエスエフ ソシエタス・ヨーロピア 活性成分の制御放出を伴う有効成分含有繊維表面構造体、その使用、およびその生産のための方法
EP2318498B1 (en) * 2008-08-28 2015-06-24 The Procter and Gamble Company Fabric care compositions, process of making, and method of use
EP2429564A1 (de) * 2009-05-15 2012-03-21 Basf Se Pharmazeutische zusammensetzungen, enthaltend antifungale peptide
NZ615847A (en) * 2009-06-03 2014-11-28 Basf Se Recombinant production of peptides
KR20120058571A (ko) 2009-08-26 2012-06-07 바스프 에스이 살생물제로서의 1,3-디올의 용도
US20120157548A1 (en) 2009-08-26 2012-06-21 Basf Se Use of cycloaliphatic diols as biocides
DE102010062662A1 (de) * 2010-12-08 2012-06-14 Henkel Ag & Co. Kgaa Wirkstoffkombination und Haarbehandlungsmittel
FR2976799B1 (fr) * 2011-06-23 2013-07-26 Oreal Composition cosmetique comprenant au moins un polymere amphotere particulier et un agent antipelliculaire.
MX2014001893A (es) * 2011-08-15 2014-05-27 Procter & Gamble Metodos para reducir el olor.
DE102011087233A1 (de) * 2011-11-28 2013-05-29 Henkel Ag & Co. Kgaa Glanzbringendes Haarbehandlungsmittel
GB201204457D0 (en) * 2012-03-14 2012-04-25 Novabiotics Ltd Polypeptides and their use
JP2015524653A (ja) * 2012-07-13 2015-08-27 ロレアル 対象における薄皮状態のインビトロ診断方法及び関連用途
WO2014093828A2 (en) 2012-12-14 2014-06-19 The Procter & Gamble Company Antiperspirant and deodorant compositions
JP6336565B2 (ja) * 2013-03-15 2018-06-06 ザ プロクター アンド ギャンブル カンパニー 微生物からの自然防御の客観的尺度として皮膚から抗微生物ペプチドを測定するための非侵襲的方法
BR112015032338A2 (pt) 2013-06-27 2017-07-25 Procter & Gamble composições e artigos para cuidados pessoais
KR101595440B1 (ko) * 2014-01-17 2016-02-18 조선대학교 산학협력단 Ｃｍ－ｍａ 펩타이드로부터 유래된 유사체 펩타이드 ｃｍａ３ 및 이의 용도
US11291616B2 (en) 2015-04-23 2022-04-05 The Procter And Gamble Company Delivery of surfactant soluble anti-dandruff agent
BR112018067494B1 (pt) 2016-03-03 2022-05-10 The Procter & Gamble Company Composição anticaspa em aerossol
CN108697910A (zh) * 2016-03-30 2018-10-23 宝洁公司 个人清洁组合物及其制备方法
EP3528897A1 (en) 2016-10-21 2019-08-28 The Procter & Gamble Company Dosage of foam for delivering consumer desired dosage volume, surfactant amount, and scalp health agent amount in an optimal formulation space
US11154467B2 (en) 2016-10-21 2021-10-26 The Procter And Gamble Plaza Concentrated shampoo dosage of foam designating hair conditioning benefits
EP3528896A1 (en) 2016-10-21 2019-08-28 The Procter & Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits
EP3528774A1 (en) 2016-10-21 2019-08-28 The Procter and Gamble Company Concentrated shampoo dosage of foam designating hair volume benefits
JP6952768B2 (ja) 2016-10-21 2021-10-20 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 低粘度であり粘度低減剤を含む、安定なコンパクトシャンプー製品
CN109862944A (zh) 2016-10-21 2019-06-07 宝洁公司 用于以最佳制剂空间递送消费者所需的剂型体积和表面活性剂量的泡沫剂型
EP3528894A1 (en) 2016-10-21 2019-08-28 The Procter and Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits
US11141370B2 (en) 2017-06-06 2021-10-12 The Procter And Gamble Company Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel
US11224567B2 (en) 2017-06-06 2022-01-18 The Procter And Gamble Company Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel
US11679073B2 (en) 2017-06-06 2023-06-20 The Procter & Gamble Company Hair compositions providing improved in-use wet feel
WO2019074989A1 (en) 2017-10-10 2019-04-18 The Procter & Gamble Company COMPACT SHAMPOO COMPOSITION CONTAINING SULFATE-FREE SURFACTANTS
JP6974928B2 (ja) 2017-10-10 2021-12-01 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company コンパクトなシャンプー組成物
US10426713B2 (en) 2017-10-10 2019-10-01 The Procter And Gamble Company Method of treating hair or skin with a personal care composition in a foam form
EP4400092A3 (en) 2017-10-10 2024-10-16 The Procter & Gamble Company Compact shampoo composition with amino acid based anionic surfactants and cationic polymers
CN111556743B (zh) 2017-12-20 2023-07-18 宝洁公司 包含硅氧烷聚合物的澄清洗发剂组合物
EP3813774A1 (en) 2018-06-29 2021-05-05 The Procter & Gamble Company Low surfactant aerosol antidandruff composition
DE102018214478A1 (de) 2018-08-28 2020-03-05 Beiersdorf Ag Acrylatfreie kosmetische Emulsion
US12226505B2 (en) * 2018-10-25 2025-02-18 The Procter & Gamble Company Compositions having enhanced deposition of surfactant-soluble anti-dandruff agents
KR102265433B1 (ko) * 2019-08-20 2021-06-15 주식회사 케어젠 발모 촉진 활성을 갖는 펩타이드 및 이의 용도
WO2021113583A1 (en) 2019-12-06 2021-06-10 The Procter & Gamble Company Sulfate free composition with enhanced deposition of scalp active
WO2021173203A1 (en) 2020-02-27 2021-09-02 The Procter & Gamble Company Anti-dandruff compositions with sulfur having enhanced efficacy and aesthetics
CN111781047A (zh) * 2020-07-03 2020-10-16 四川恒健生物科技有限公司 一种用于血液分析的溶血素及其制备方法、试剂
WO2022109094A1 (en) 2020-11-23 2022-05-27 The Procter & Gamble Company Personal care compositions free of sulfated surfactants
IL303390A (en) 2020-12-03 2023-08-01 Battelle Memorial Institute Compositions of polymer nanoparticles and DNA nanostructures and methods for non-viral transport
JP7768985B2 (ja) 2020-12-04 2025-11-12 ザ プロクター アンド ギャンブル カンパニー 悪臭低減物質を含むヘアケア組成物
FR3117599B1 (fr) * 2020-12-16 2024-11-29 Oreal Méthode de pronostic et/ou de diagnostic d’un état pelliculaire du cuir chevelu
WO2022216977A1 (en) 2021-04-07 2022-10-13 Batelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
US12409125B2 (en) 2021-05-14 2025-09-09 The Procter & Gamble Company Shampoo compositions containing a sulfate-free surfactant system and sclerotium gum thickener
US11986543B2 (en) 2021-06-01 2024-05-21 The Procter & Gamble Company Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants
EP4129319A1 (en) * 2021-08-02 2023-02-08 Masarykova univerzita Pore-forming antimicrobial peptides
CA3235522A1 (en) 2021-12-09 2023-06-15 The Procter & Gamble Company Sulfate free personal cleansing composition comprising effective preservation
CN114983853A (zh) * 2022-06-16 2022-09-02 山东福瑞达生物股份有限公司 一种低粘稳定的d相乳液及其制备方法
CN116874614B (zh) * 2023-09-06 2023-11-17 南京华盖制药有限公司 一种具有高活性低裂解效果的抗菌多肽aph171及其制备方法和应用
CN116874613B (zh) * 2023-09-06 2023-11-17 南京华盖制药有限公司 一种广谱高效的抗菌多肽aph143及其制备方法和应用
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
AU2024393766A1 (en) 2023-12-08 2026-06-18 Battelle Memorial Institute Use of dna origami nanostructures for molecular information based data storage systems
WO2025174058A1 (ko) * 2024-02-15 2025-08-21 (주)뉴트리 탈모 유발 유해균에 대한 항균 효과를 갖는 두피 유래 펩타이드
FR3165392A1 (fr) * 2024-08-07 2026-02-13 L'oreal Composition cosmétique comprenant des tensioactifs anioniques sulfate et sulfonate, et de l’eau en une teneur particulière
FR3165393A1 (fr) * 2024-08-07 2026-02-13 L'oreal Composition cosmétique comprenant des tensioactifs anioniques sulfatés, des agents conditionneurs et de l’eau en une teneur particulière
FR3165391A1 (fr) * 2024-08-07 2026-02-13 L'oreal Composition cosmétique comprenant des tensioactifs anioniques sulfatés et non sulfatés, et de l’eau, dans un rapport pondéral particulier

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6255279B1 (en) 1995-12-16 2001-07-03 Beiersdorf Ag Cosmetic preparations containing vertebrate proteins and having antibacterial, antimycotical and antiviral action
JPH11106399A (ja) * 1997-10-01 1999-04-20 Morinaga Milk Ind Co Ltd ペプチド誘導体および抗真菌剤
CA2352749A1 (en) * 1998-11-30 2000-06-08 Novozymes A/S Anti-dandruff composition comprising an antifungal polypeptide
FR2786689A1 (fr) * 1998-12-03 2000-06-09 Oreal Composition cosmetique ou dermatologique comprenant au moins un alkynyl carbamate et au moins un polyol
US20030143234A1 (en) * 1999-08-20 2003-07-31 Wenyuan Shi Anti-microbial targeting chimeric pharmaceutical
CN1454214A (zh) * 2000-08-02 2003-11-05 赛莱技术公司 具有增高功效的修饰生物肽
JP2002253245A (ja) * 2001-02-28 2002-09-10 Toyota Central Res & Dev Lab Inc 融合タンパク質
KR20030013189A (ko) * 2001-08-07 2003-02-14 주식회사 코메드 파골세포 분화를 억제하는 펩타이드 ｐ1
KR100438416B1 (ko) * 2001-09-19 2004-07-02 학교법인조선대학교 Ｃａ－ｍａ 펩타이드의 아미노산 중 하나 또는 그 이상을치환하여 ＋ 전극과 소수성 영역이 증가된 신규한펩타이드 및 그를 포함하는 약학적 조성물
US20050058689A1 (en) * 2003-07-03 2005-03-17 Reactive Surfaces, Ltd. Antifungal paints and coatings
CN1245418C (zh) 2002-12-30 2006-03-15 上海高科联合生物技术研发有限公司 一组新的合成抗菌肽及其制备方法和应用
SE0401942D0 (sv) * 2004-07-28 2004-07-28 Lipopeptide Ab New antimicrobial peptide complexes
ITRM20040349A1 (it) * 2004-07-13 2004-10-13 Univ Siena Peptidi antibatterici e loro analoghi.
CN1896107A (zh) * 2006-06-13 2007-01-17 南京农业大学 类天蚕素a－马盖宁杂合基因工程抗菌肽
EP2224901A1 (en) * 2007-12-21 2010-09-08 Basf Se Anti-dandruff compositions containing peptides
CN101302249B (zh) 2008-06-24 2011-08-17 四川大学 一种自组装短肽及其在制备抗肿瘤药物中的应用

Also Published As

Publication number Publication date
KR101417202B1 (ko) 2014-07-16
CN101903011B (zh) 2014-08-06
CN101903011A (zh) 2010-12-01
KR101425331B1 (ko) 2014-08-01
WO2009080306A8 (en) 2011-02-24
US20100310644A1 (en) 2010-12-09
WO2009080306A1 (en) 2009-07-02
RU2491052C2 (ru) 2013-08-27
JP5688293B2 (ja) 2015-03-25
US8765688B2 (en) 2014-07-01
EP2224901A1 (en) 2010-09-08
JP2011508728A (ja) 2011-03-17
RU2010129845A (ru) 2012-01-27
CA2708554C (en) 2014-04-22
KR20130083484A (ko) 2013-07-22
CA2708554A1 (en) 2009-07-02
KR20100101155A (ko) 2010-09-16

Similar Documents

Publication Publication Date Title
CL2013000074A1 (es) Proteina de union con capacidad de unir un par de antigenos; acido nucleico que la codifica; vector; celula huesped; metodo de produccion; composicion farmaceutica que la comprende; conjugado que comprende dicha proteina de union; y sus usos.
BRPI1013640A2 (pt) composicao farmaceutica, metodos para o tratamento e usos dos mesmos
DK2300472T3 (da) Glucocorticoidmimetika, fremgangsmåder til disses fremstilling, farmaceutiske sammensætninger samt anvendelser deraf
BR112013015816A2 (pt) construção de dna para imunomodulação, composição farmacêutica, vacina e uso de uma construção de dna
DK2297385T3 (da) Polymere sammensætninger, som omfatter polymælkesyre, og fremgangsmåder til fremstilling og anvendelse deraf
AR092487A2 (es) Anticuerpos contra la angiopoyetina 2 humana
BR112013011705A2 (pt) antígenos consensuais de próstata, molécula de ácido nucleico que os codificam e vacina e usos que os compreendem
BRPI0914549A2 (pt) produção, formulação de usos de formulações estáveis de proteína harpina líquidas
CL2013001282A1 (es) Sal succinato de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]-pirimidin-6-carboxilico; composicion farmaceutica que la comprende y procesos para su preparacion.
BRPI0919466A2 (pt) composição farmacêutica para liberação modificada
DK4342987T3 (da) Sammensætning til spaltning af et mål-dna omfattende et guide-rna specifikt for mål-dna'et og cas-protein-kodende nukleinsyre eller cas-protein, og anvendelser deraf
BRPI1009372A2 (pt) compostos, composição farmacêutica e respectivos usos
BRPI0918360A2 (pt) composto, composição farmacêutica e usos de um composto
CL2013001831A1 (es) Proteina de enlace multivalente y multiespecifica que une a il-1 alfa y beta; conjugado que la comprende; acido nucleico que la codifica; vector; celula huesped; metodo de produccion; composicion farmaceutica que la comprende; y sus usos.
BR112013018877A2 (pt) composições farmacêuticas que compreendem anticorpos humanos para pcsk9
BR112012014962A2 (pt) métodos e composições para formulações líquidas e estáveis de fármacos
BRPI0816330A2 (pt) Composição de polipeptídeo, método para produzir composição de polipeptídeo, construção de polipeptídeo, método para produzir uma construção de polipeptídeo, construção de ácido nucleico, medicamento ou composição de vacina, método para produzir um medicamento ou composição de vacina, e uso da composição de polipeptídeo, de uma construção de polipeptídeo, de uma construção de ácido nucléico ou de um medicamento ou de composição de vacina
EA201070421A1 (ru) Микрорибонуклеиновые кислоты
BRPI1006435A2 (pt) "moléculas de ácidos nucleicos e polipeptídeos da sintase do ácido graxo poli-insaturado, composições, métodos de produção e uso dos mesmos"
ZA201208336B (en) Controlled release pharmaceutical compositions of tapentadol
BR112014012681A8 (pt) polipeptídeo, métido para proporcionar um polipeptídeo, ácido nucleico, e, composição imunogênica
BR112013011868A2 (pt) compostos de pirimidina hidróxi amida como inibidores da proteína desacetilase, composição farmacêutica e uso dos referidos compostos
DK3287123T3 (da) Vandig farmaceutisk formulering af tapentadol til oral administration
BR112014022788A2 (pt) peptídeo, polipeptídeos, ácido nucleico, composição farmacêutica, conjugado e método in vitro
BR112014010290A2 (pt) composição farmacêutica, métodos, composições e usos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O ART. 8O COMBINADO COM ART. 13 E ART. 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.